Search
for
Sort by
Research 841–870 of 1000+
- State-dependent signaling by Ca<sub>v</sub>1.2 regulates hair follicle stem cell function
- 5alpha-reductase 2 inhibition impairs brain defeminization of male rats: Reproductive aspects
- The first clinical trial of topical application of procyanidin B‐2 to investigate its potential as a hair growing agent
- Acute telogen effluvium associated with SARS-CoV-2 infection
- Low-dose (2.5 mg/day) finasteride treatment in hirsutism
- Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus
- The role of SARS‐CoV‐2 infection and its vaccines in various types of hair loss
- A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection
- EZH2-mediated inhibition of microRNA-22 promotes differentiation of hair follicle stem cells by elevating STK40 expression
- Genetic association of complement component 2 polymorphism with systemic lupus erythematosus
- Preparation of 4-aryl-2-trifluoromethylbenzonitrile derivatives as androgen receptor antagonists for topical suppression of sebum production
- Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
- Pharmacokinetics of 2 Novel Formulations of Modified-Release Oral Testosterone Alone and With Finasteride in Normal Men With Experimental Hypogonadism
- Prefrontal 5α-reductase 2 mediates male-specific acute stress response
- 62823 Optimization of deuruxolitinib dosing in adult patients with alopecia areata: Results from a randomized, parallel-group, multicenter, Phase 2 trial
- The most common skin symptoms in young adults and adults related to SARS-CoV-2 virus infection
- SARS-CoV-2 vaccination complicated by small fiber neuropathy, mast cell activation syndrome, and pericarditis
- Efficacy of 2.5 mg oral biotin versus 5% topical minoxidil in increasing nail growth rate
- Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review
- Ultrastructural evidence for anagen hair follicle infection with SARS‐CoV‐2 in early‐onset COVID‐19 effluvium
- Letter in Reply: Alopecia areata after SARS-CoV-2 vaccination
- Acute Telogen Effluvium in Patients Recently Infected with SARS-CoV-2
- SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation
- Intermolecular NH 2 -/Carboxyl-terminal Interactions in Androgen Receptor Dimerization Revealed by Mutations That Cause Androgen Insensitivity
- TMPRSS2, required for SARS-CoV-2 entry, is downregulated in lung cells by enzalutamide, a prostate cancer therapeutic
- 265 Modulation of disease-central cytokine pathways with TAK-279, a highly selective oral tyrosine kinase 2 (TYK2) inhibitor, defines clinical response in patients with psoriasis
- A case of telogen effluvium followed by alopecia areata after SARS‐CoV‐2 infection
- Spontaneous complete resolution of alopecia totalis post SARS-CoV-2 infection
- 26143 Time to scalp hair, eyebrow, and eyelash improvement in patients with alopecia areata treated with baricitinib in the phase 2 portion of the phase 2/3 BRAVE-AA1 study
- G.P.2.16 Valproate, acetylcarnitine, folic acid and vitamin B12 in spinal muscular atrophy: Preliminary data of an open-label study in children